Australian Clinical Labs Limited (ASX:ACL)
2.620
+0.020 (0.77%)
Sep 8, 2025, 4:10 PM AEST
Australian Clinical Labs Company Description
Australian Clinical Labs Limited provides pathology diagnostic services in Australia.
The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs.
It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Australian Clinical Labs Limited
Country | Australia |
Founded | 2020 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 4,700 |
CEO | Melinda McGrath |
Contact Details
Address: 1868-1892 Dandenong Road Clayton, 3168 Australia | |
Phone | 61 1 3004 53688 |
Website | clinicallabs.com.au |
Stock Details
Ticker Symbol | ACL |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU0000148496 |
SIC Code | 8071 |
Key Executives
Name | Position |
---|---|
Rob Izzard | Chief Executive Officer of ACL Commercial Pathology |
Shae Seymour | Chief Executive Officer of WA/SA/NT |
Chris Brownlow | Chief Executive Officer of New South Wales and Australian Capital Territory |
Melinda McGrath | Chief Executive Officer and Executive Director |
Matthew Cordingley | Chief Financial Officer |
Anthony Friedli | Chief Operating Officer |
Sean Jackson | Chief Information Officer |
Joe Geran | National Marketing Director |
Associate Prof. Tony Landgren | National Medical Director and Chief Pathologist |
Eleanor Padman B.A., FCIS | Company Secretary |